Mesa Laboratories, Inc.
MLAB
$105.48
-$1.87-1.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.56% | 3.64% | 5.02% | 2.36% | 5.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.56% | 3.64% | 5.02% | 2.36% | 5.49% |
| Cost of Revenue | -9.29% | 1.06% | 6.76% | 12.22% | 12.33% |
| Gross Profit | 9.87% | 5.13% | 3.96% | -2.86% | 1.66% |
| SG&A Expenses | 7.42% | -0.45% | 0.90% | 7.27% | 13.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.51% | 0.16% | 3.98% | 9.01% | 11.47% |
| Operating Income | 87.07% | 38.00% | 19.23% | -51.81% | -67.20% |
| Income Before Tax | -445.55% | 307.31% | -47.56% | 79.56% | 100.17% |
| Income Tax Expenses | -66.43% | 278.56% | -224.22% | 339.07% | 136.51% |
| Earnings from Continuing Operations | 41.86% | 316.59% | -27.77% | 39.96% | 97.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.86% | 316.59% | -27.77% | 39.96% | 97.21% |
| EBIT | 87.07% | 38.00% | 19.23% | -51.81% | -67.20% |
| EBITDA | -5.22% | 21.41% | 5.41% | -23.70% | -16.77% |
| EPS Basic | 42.97% | 312.57% | -29.07% | 38.21% | 97.23% |
| Normalized Basic EPS | -438.87% | 303.49% | -53.98% | 285.53% | 6.43% |
| EPS Diluted | 42.97% | 309.68% | -28.70% | 37.10% | 97.23% |
| Normalized Diluted EPS | -438.87% | 302.27% | -53.68% | 281.26% | 6.43% |
| Average Basic Shares Outstanding | 1.93% | 1.90% | 1.83% | 1.26% | 0.83% |
| Average Diluted Shares Outstanding | 1.93% | 2.51% | 1.17% | 2.38% | 0.83% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.75% | 1.47% | 0.41% | -0.28% | -35.04% |